OnKure Therapeutics Files 2025 Annual Report
Ticker: OKUR · Form: ARS · Filed: Apr 21, 2026 · CIK: 0001637715
Sentiment: neutral
Topics: annual-report, pharmaceuticals, sec-filing
TL;DR
OnKure Therapeutics filed its 2025 ARS on 4/21/26. Check it for 2025 performance.
AI Summary
OnKure Therapeutics, Inc. filed its Annual Report to Security Holders (ARS) on April 21, 2026, for the period ending December 31, 2025. The company, located in Boulder, CO, is involved in the Pharmaceutical Preparations industry. This filing provides a summary of the company's performance and financial status for the fiscal year 2025.
Why It Matters
This ARS filing provides shareholders and potential investors with a comprehensive overview of OnKure Therapeutics' operations and financial health for the 2025 fiscal year, aiding in investment decisions.
Risk Assessment
Risk Level: medium — As an ARS filing, it provides a historical overview, but the company's specific financial performance and future outlook require further analysis beyond this report.
Key Numbers
- 2025-12-31 — Fiscal Year End (The period covered by the Annual Report to Security Holders.)
- 0001637715 — CIK Number (Unique identifier for OnKure Therapeutics, Inc. in SEC filings.)
Key Players & Entities
- OnKure Therapeutics, Inc. (company) — Filer of the ARS
- 0001637715 (company) — CIK number for OnKure Therapeutics, Inc.
- 2026-04-21 (date) — Filing date of the ARS
- 2025-12-31 (date) — Period of report for the ARS
- 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (location) — Mailing and Business Address for OnKure Therapeutics, Inc.
FAQ
What is the primary purpose of the ARS filing?
The ARS (Annual Report to Security Holders) provides a summary of the company's performance and financial status for the fiscal year ending December 31, 2025.
When was the ARS filing accepted by the SEC?
The ARS filing was accepted by the SEC on April 21, 2026.
What is OnKure Therapeutics, Inc.'s business address?
OnKure Therapeutics, Inc.'s business address is 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301.
What industry does OnKure Therapeutics, Inc. operate in?
OnKure Therapeutics, Inc. operates in the Pharmaceutical Preparations industry (SIC code 2834).
What is the CIK number for OnKure Therapeutics, Inc.?
The CIK number for OnKure Therapeutics, Inc. is 0001637715.
Filing Details
This Form ARS (Form ARS) was filed with the SEC on April 21, 2026 regarding OnKure Therapeutics, Inc. (OKUR).